KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX, page-2

  1. mw03
    2,136 Posts.
    lightbulb Created with Sketch. 61
    clock Created with Sketch.
    31/10/16
    09:47
    Post #: 20241248
    Q If it is so good, why would Roche sell it?
    NRT Price at posting: 8.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
NEWS Want to talk crypto? Click here to join the discussion!
right-arrow Created with Sketch.
MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.